FLQY2, a camptothecin analogue, exhibits remarkable antitumor efficacy against various solid tumors. This compound demonstrates both in vivo and in vitro activity against pancreatic cancer, inhibiting cell proliferation, colony formation at nanomolar concentrations, inducing apoptosis (Apoptosis), and causing cell cycle arrest.